Posted by Michael Wonder on 07 Jul 2021
WHO recommends life-saving interleukin 6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access
7 July 2021 - The World Health Organization (WHO) has updated its patient care guidelines to include interleukin-6 receptor blockers, a class of medicines that are lifesaving in patients who are severely or critically ill with COVID-19, especially when administered alongside corticosteroids.
To increase access and affordability of these life-saving products, WHO calls on manufacturers to reduce prices and make supplies available to low- and middle-income countries, especially where COVID-19 is surging.
